Who owns BLTE?
Institutional ownership of Belite Bio Inc from Form 13F, Q2 2026
81 institutional managers reported holding Belite Bio Inc (BLTE) in Form 13F filings for Q2 2026, with 9,473,460 shares worth $1.4B. The largest reported holder was Darwin Global Management, Ltd. Managers that filed both quarters added a net 356,933 shares (+3.9%). 22 opened new positions and 16 sold out.
- Funds holding
- 81
- Value held
- $1.4B
- New / sold out
- 22 / 16
- Net shares, same filers
- +3.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of BLTE
Share of 13F holdings is each fund's shares as a share of the 9,473,460 BLTE shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Maverick Capital LTD New+$61.0M
- Logos Global Management LP New+$38.5M
- Citadel Advisors LLC Added+$28.4M
- Bank of America Corp Added+$18.6M
- Paradigm Biocapital Advisors LP Added+$18.2M
- Affinity Asset Advisors, LLC Added+$15.4M
- Goldman Sachs Group Inc Added+$9.3M
- Jane Street Group, LLC Added+$8.3M
- Deerfield Management Company, L.p. Added+$8.2M
- Point72 Asset Management, L.P. New+$7.9M
Biggest sellers in Q2 2026
- UBS Group AG Trimmed-$83.7M
- Holocene Advisors, LP Trimmed-$37.5M
- Price T Rowe Associates Inc Trimmed-$27.1M
- Perceptive Advisors LLC Sold out-$24.2M
- Millennium Management LLC Trimmed-$11.6M
- Fred Alger Management, LLC Trimmed-$9.3M
- Longaeva Partners L.P. Sold out-$5.3M
- ADAR1 Capital Management, LLC Sold out-$4.3M
- PFM Health Sciences, LP Trimmed-$3.8M
- Quadrature Capital Ltd Sold out-$3.8M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $286M and sold $232M; 28 added and 22 trimmed.
Schedule 13D and 13G filings on BLTE
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-12-10Darwin Global Management, Ltd. SCHEDULE 13G filed by Belite Bio IncSchedule 13G
Questions about BLTE ownership
- Who owns BLTE stock?
- 81 institutional investment managers reported BLTE positions in their Form 13F filings for Q2 2026, holding 9,473,460 shares worth $1.4B in total. Darwin Global Management, Ltd. reported the largest position.
- Are funds buying or selling BLTE?
- In Q2 2026, 22 managers opened new BLTE positions, 28 added, 22 trimmed and 16 sold out. Managers that filed in both quarters added a net 356,933 shares.
- How current is this BLTE institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to BLTE by CUSIP. Options are left out. BLTE news and filings · BLTE insider trades · Top funds